Upstream Bio, Inc. (UPB) stock
UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.10−0.05 (-2.33%)
Close on Nov 17, 2026Market cap $115.02MP/E –Yield –
Upstream Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Upstream Bio's operating cash flow for the twelve months ending Sep 30, 2026 was -$168.33M. For fiscal 2025 it was -$133.28M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$133.28M | – |
| FY2024 | Dec 31, 2024 | -$59.17M | – |
| FY2023 | Dec 31, 2023 | -$37.93M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$54.23M | – |
| Q2 FY2026 | Jun 30, 2026 | -$35.62M | – |
| Q1 FY2026 | Mar 31, 2026 | -$47.85M | – |
| Q4 FY2025 | Dec 31, 2025 | -$30.63M | – |
| Q3 FY2025 | Sep 30, 2025 | -$22.24M | – |
| Q2 FY2025 | Jun 30, 2025 | -$39.24M | – |
| Q1 FY2025 | Mar 31, 2025 | -$41.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$19.61M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.96M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.04M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.56M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.11M | – |
See a number that looks wrong?